Given evidence that changes in T cells can influence Aβ pathology (Da Mesquita et al., 2021; Marsh et al., 2016), this presents an important yet unstudied aspect of CSF1R antagonists in the context of AD. This evidence concerns the gene CSF1R and Alzheimer disease.